166 related articles for article (PubMed ID: 15090235)
1. Development of displacement binding and GTPgammaS scintillation proximity assays for the identification of antagonists of the micro-opioid receptor.
Rodgers G; Hubert C; McKinzie J; Suter T; Statnick M; Emmerson P; Stancato L
Assay Drug Dev Technol; 2003 Oct; 1(5):627-36. PubMed ID: 15090235
[TBL] [Abstract][Full Text] [Related]
2. A 1,536-well [(35)S]GTPgammaS scintillation proximity binding assay for ultra-high-throughput screening of an orphan galphai-coupled GPCR.
Johnson EN; Shi X; Cassaday J; Ferrer M; Strulovici B; Kunapuli P
Assay Drug Dev Technol; 2008 Jun; 6(3):327-37. PubMed ID: 18537464
[TBL] [Abstract][Full Text] [Related]
3. Dimethyl sulfoxide: an antagonist in scintillation proximity assay [(35)S]-GTPgammaS binding to rat 5-HT(6) receptor cloned in HEK-293 cells?
Mereghetti I; Cagnotto A; Mennini T
J Neurosci Methods; 2007 Mar; 160(2):251-5. PubMed ID: 17049618
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel "almost neutral" micro-opioid receptor antagonist in CHO cells expressing the cloned human mu-opioid receptor.
Sally EJ; Xu H; Dersch CM; Hsin LW; Chang LT; Prisinzano TE; Simpson DS; Giuvelis D; Rice KC; Jacobson AE; Cheng K; Bilsky EJ; Rothman RB
Synapse; 2010 Apr; 64(4):280-8. PubMed ID: 19953652
[TBL] [Abstract][Full Text] [Related]
5. Use of scintillation proximity assay to measure radioligand binding to immobilized receptors without separation of bound from free ligand.
Berry J; Price-Jones M; Killian B
Methods Mol Biol; 2012; 897():79-94. PubMed ID: 22674161
[TBL] [Abstract][Full Text] [Related]
6. A fully automated [35S]GTPgammaS scintillation proximity assay for the high-throughput screening of Gi-linked G protein-coupled receptors.
Ferrer M; Kolodin GD; Zuck P; Peltier R; Berry K; Mandala SM; Rosen H; Ota H; Ozaki S; Inglese J; Strulovici B
Assay Drug Dev Technol; 2003 Apr; 1(2):261-73. PubMed ID: 15090191
[TBL] [Abstract][Full Text] [Related]
7. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
8. Development of a scintillation proximity assay binding method for the human 5-hydroxytryptamine 6 receptor using intact cells.
Carrick T; Kowal D; Nawoschik S; Zhang G; Chan K; Dunlop J
Anal Biochem; 2008 Oct; 381(1):27-32. PubMed ID: 18601889
[TBL] [Abstract][Full Text] [Related]
9. Functional role of a conserved motif in TM6 of the rat mu opioid receptor: constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp.
Huang P; Li J; Chen C; Visiers I; Weinstein H; Liu-Chen LY
Biochemistry; 2001 Nov; 40(45):13501-9. PubMed ID: 11695897
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of forebrain μ-opioid receptor signaling by low concentrations of rimonabant does not require cannabinoid receptors and directly involves μ-opioid receptors.
Zádor F; Otvös F; Benyhe S; Zimmer A; Páldy E
Neurochem Int; 2012 Aug; 61(3):378-88. PubMed ID: 22613132
[TBL] [Abstract][Full Text] [Related]
11. Solubilization and reconstitution of the mu-opioid receptor expressed in human neuronal SH-SY5Y and CHO cells.
Talmont F; Moulédous L; Mollereau C; Zajac JM
Peptides; 2014 May; 55():79-84. PubMed ID: 24582609
[TBL] [Abstract][Full Text] [Related]
12. Development of a homogeneous binding assay for histamine receptors.
Crane K; Shih DT
Anal Biochem; 2004 Dec; 335(1):42-9. PubMed ID: 15519569
[TBL] [Abstract][Full Text] [Related]
13. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
14. Identification of non-peptidic neuromedin U receptor modulators by a robust homogeneous screening assay.
Meng T; Su HR; Binkert C; Fischli W; Zhou L; Shen JK; Wang MW
Acta Pharmacol Sin; 2008 Apr; 29(4):517-27. PubMed ID: 18358099
[TBL] [Abstract][Full Text] [Related]
15. Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects.
Szekeres PG; Traynor JR
J Pharmacol Exp Ther; 1997 Dec; 283(3):1276-84. PubMed ID: 9400003
[TBL] [Abstract][Full Text] [Related]
16. Anti-mu opioid antiserum against the third external loop of the cloned mu-opioid receptor acts as a mu receptor neutral antagonist.
Guarna M; Bartolini A; Ghelardini C; Galeotti N; Bracci L; Stefano GB; Bianchi E
Brain Res Mol Brain Res; 2003 Nov; 119(1):100-10. PubMed ID: 14597234
[TBL] [Abstract][Full Text] [Related]
17. The antibody-capture [(35)S]GTPgammaS scintillation proximity assay: a powerful emerging technique for analysis of GPCR pharmacology.
DeLapp NW
Trends Pharmacol Sci; 2004 Aug; 25(8):400-1. PubMed ID: 15276707
[No Abstract] [Full Text] [Related]
18. Synthesis and pharmacological evaluation of novel octahydro-1H-pyrido[1,2-a]pyrazine as mu-opioid receptor antagonists.
Le Bourdonnec B; Goodman AJ; Graczyk TM; Belanger S; Seida PR; DeHaven RN; Dolle RE
J Med Chem; 2006 Dec; 49(25):7290-306. PubMed ID: 17149859
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
Alt A; McFadyen IJ; Fan CD; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2001 Jul; 298(1):116-21. PubMed ID: 11408532
[TBL] [Abstract][Full Text] [Related]
20. Endomorphin-1 induced desensitization and down-regulation of the recombinant mu-opioid receptor.
Harrison C; Rowbotham DJ; Grandy DK; Lambert DG
Br J Pharmacol; 2000 Nov; 131(6):1220-6. PubMed ID: 11082131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
